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ABSTRACT 
 
Background: Estrogen deficiency increases body weight or total and central 
adiposity and decreases energy expenditure. Hypothalamic neuropeptide Y (NPY) 
expression is altered by estrogen deficiency in rodents, but the long-term 
consequences on energy homeostasis are unknown. 
Objective: To investigate the role of NPY in the changes in energy expenditure 
and physical activity, as well as the associated changes in body weight and 
composition in response to short-term and long-term estrogen deficiency. 
Design: Sham and ovariectomy (OVX) operations were performed at 8 weeks of 
age in wild-type (WT) and NPY−/− mice. Energy expenditure, physical activity, 
body composition and weight, as well as food intake were measured at 10–18 
days (short-term) and 46–54 days (long-term) after OVX. 
Results: OVX influences energy homeostasis differently at early compared with 
later time-points. At the early but not the late time point, OVX in WT mice 
reduced oxygen consumption and energy expenditure and tended to reduce 
resting metabolic rate. Interestingly, these effects of short-term estrogen 
deficiency were ablated by NPY deletion, with NPY−/− mice exhibiting significant 
increases in energy expenditure and resting metabolic rate. In addition to these 
hypermetabolic effects, OVX NPY−/− mice exhibited significantly lower body weight 
and whole-body fat mass relative to OVX WT controls at the short-term but not 
the long-term time point. Food intake and physical activity were unaltered by 
OVX, but NPY−/− mice exhibited significant reductions in these parameters relative 
to WT. 
Conclusion: The effects of estrogen deficiency to reduce energy metabolism are 
transient, and NPY is critical to this effect as well as the early OVX-induced 
obesity. 
 
INTRODUCTION 
Menopause is associated with weight gain and increased adiposity (particularly 
visceral adiposity).bib11, bib22, bib33 Given the contribution of excess weight and 
central obesity to pathologies, such as insulin resistance, diabetes and 
cardiovascular disease,bib44, bib55, bib66 identifying the mechanisms contributing to 
menopause-induced weight gain could lead to improved means of attenuating 
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these pathologies. Ovariectomy (OVX) in animals, a model of menopause, 
induces increases in body weight and total adiposity,bib77, bib88, bib99, bib1010 
consistent with effects of menopause in women.bib11, bib22, bib33 Importantly, lack of 
estrogens in humans is also associated with reductions in lean body mass and 
muscle strength,bib1111, bib1212 perhaps explaining why menopause is consistently 
associated with increases in total and/or visceral fat,bib77, bib88, bib99, bib1010, bib1313 but 
not always with increased body weight.bib1414, bib1515 Administration of exogenous 
estrogens to OVX animals or estrogen-deficient women reduces body weight gain, 
prevents abdominal or visceral fat gain, and reduces loss of fat-free mass and 
muscle strength,bib1010, bib1616, bib1717 demonstrating the pivotal role of estrogens in 
regulating body weight and composition. 
 Alterations in food intake are unlikely to have a long-term role in 
sustaining the positive energy balance associated with OVX or menopause. In 
rodents, food intake was increased at 2 and 3 weeks following OVX,bib77, bib1818 
however, this OVX-induced hyperphagia appears transient, with food intake 
normalized within 5–7 weeks post surgery.bib77, bib1818 A longitudinal study 
following women transitioning through menopause shows no difference in energy 
intake at 2 years after the complete cessation of menses compared with that 
measured before menopause, despite increased body weight.bib1919 In fact, 3–4 
years before the onset of menopause, dietary energy, protein, carbohydrate and 
fiber intake were significantly higher than corresponding intakes measured at the 
onset of menopause.bib1919 Thus, if energy intake is not consistently elevated 
when ovarian estrogens are lacking, reductions in energy expenditure may 
contribute to the associated weight and fat gain. 
 Women transitioning through menopause display marked decreases in 
energy expenditure and spontaneous physical activity.bib1919 However, it cannot 
be determined whether these changes were permanent or transient because of 
the limited follow-up period of that study (2 years). Animals also show a drop in 
energy expenditure and physical activity in response to OVX.bib2020 However, 
these changes were measured at 22 weeks after surgery, thus it is not known 
whether these responses to estrogen deficiency are stronger in the early period 
after estrogen deficiency, as is suggested by the transient increase in food intake 
in OVX rodents.bib77, bib1818 Identifying the time course and mechanisms with which 
these decreases in energy expenditure and physical activity occur during estrogen 
deficiency could allow optimization of timing of intervention programs aimed at 
attenuating menopause-induced weight or fat gain. 
 The hypothalamus is likely to have a critical role in the estrogen-mediated 
regulation of energy expenditure and physical activity via actions through 
estrogen receptors (ERα and ERβ).bib2121, bib2222, bib2323, bib2424, bib2525 One of the 
major regulators of energy expenditure and physical activity in the central 
nervous system—and a target for the effects of estrogen deficiency—is 
neuropeptide Y (NPY), a potent orexigenic peptide primarily expressed in the 
hypothalamic arcuate nucleus. Centrally-administered NPY acutely stimulates 
hyperphagia, and repeated doses increase body weight and adiposity.bib2626 In 
addition, NPY can reduce energy expenditure and physical activity.bib2727 Marked 
increases in hypothalamic NPY gene expression have been described in post-
mortem samples from post-menopausal women (59–86 years of age) when 
compared with that of young women (21–39 years of age).bib2828 In rodents, there 
is also a consistent increase in hypothalamic NPY expression in response to OVX, 
but this appears to be transient as it is only observed at 2 and 3 weeks but not at 
4–7 weeks following OVX.bib77, bib2929, bib3030 The transient increase in NPY 
expression in response to estrogen deficiency may contribute to the transient 
hyperphagia and may also initiate the reduction in energy expenditure and 
physical activity evident following estrogen deficiency. However, there is no direct 
evidence for the role of NPY in mediating hyperphagia and the reductions in 
energy expenditure and physical activity in response to estrogen deficiency. 
In order to determine the role of NPY in the changes in energy expenditure and 
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physical activity, as well as the associated changes in body weight and 
composition with estrogen deficiency, we compared the effects of OVX on these 
parameters in wild-type (WT) and NPY knockout (NPY−/−) mice. Moreover, to 
determine whether the decreases in energy expenditure and physical activity that 
have been observed with estrogen deficiency may be more marked in the early 
than in the later stages of estrogen deficiency, we investigated the effect of 
estrogen deficiency on these parameters at both short- and long-term time points 
after OVX, when food intakebib77, bib1818 and hypothalamic NPY expression are 
known to be different.bib77, bib2929, bib3030 
MATERIALS AND METHODS 
Animals 
All research and animal care procedures were approved by the Garvan 
Institute/St Vincent′s Hospital Animal Ethics Committee and were in agreement 
with the Australian Code of Practice for the Care and Use of Animals for Scientific 
Purpose. Mice were housed under conditions of controlled temperature (22 °C) 
and illumination (12-h light cycle). All mice were fed a normal chow diet (2.6 kcal 
g−1; Gordon′s Specialty Stock Feeds, Yanderra, New South Wales Australia). Food 
and water were available ad libitum unless otherwise stated. Details of generation 
of the germline NPY knockout mice (NPY−/−) were published previously.bib3131 OVX 
and sham operations were performed on female WT and NPY−/− mice at 8 weeks 
of age as described previously.bib2020 Uterine weights were measured at the end of 
the study to confirm the success of OVX procedures as described previously.bib1010 
. 
Food intake 
Food intake was measured at 8–14 and 45–48 days post surgery. These time 
points are referred to as ‘short-term’ and ‘long-term’ effects of surgery. Food 
intake for each mouse was determined as the average of measurements taken 
over four consecutive days, with actual food intake (as opposed to food spillage) 
being determined as described previously.bib3232 
. 
Indirect calorimetry 
Energy expenditure was determined with indirect calorimetry (Oxymax Series; 
Columbus Instruments, Columbus, OH, USA) as described previously.bib3232 
Measurements were performed at 14–18 and 50–54 days post surgery (‘short-
term’ and ‘long-term’ effects of surgery). Pre-weighed mice were housed 
individually in specially built plexiglass cages (20.1 × 10.1 × 12.7 cm3). They 
were left to acclimatize to the cages for 24 h before 72 h recordings commenced. 
Temperature was maintained at 22 °C with airflow of 0.6 l min–1. Oxygen 
consumption (VO2) and carbon dioxide production (VCO2) were measured every 
27 min. The respiratory exchange ratio (RER) was calculated as the quotient of 
VCO2/VO2, with 100% carbohydrate oxidation resulting in an RER of 1, and 100% 
fat oxidation resulting in an RER of 0.7.bib3333, bib3434 Energy expenditure (kcal heat 
produced) was calculated as calorific value (CV) x VO2, where CV is 3.815+1.232 
x RER.bib3535 Data for the 72-h monitoring period was averaged for 1-h intervals 
for energy expenditure and RER. Actual food intake was determined during 
indirect calorimetry over four consecutive days, taking into account food spillage. 
. 
Measurement of physical activity and resting metabolic rate 
Ambulatory activity of individually housed mice was evaluated at the same time 
as measurement of energy expenditure via indirect calorimetry, using an OPTO-
M3 sensor system (Columbus Instruments, Columbus, OH, USA). Consecutive 
adjacent photo-beam breaks were counted as ambulatory counts. Cumulative 
ambulatory counts of X and Y directions were recorded every minute and 
summed for 1-h intervals as previously described.bib3232 In order to elucidate the 
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contribution of possible changes in physical activity to changes in energy 
expenditure, resting metabolic rate was estimated using correlation analysis 
between physical activity and energy expenditure as previously described.bib3636 
. 
Analysis of body composition 
Immediately upon completion of indirect calorimetry and physical activity 
measurements, animals were anesthetized and then scanned using dual-energy 
X-ray absorptiometry (Lunar PIXImus; GE Healthcare, Madison, WI, USA) to 
determine whole-body fat and lean mass. The head was excluded from analyses 
of body composition. 
. 
Tissue collection 
At 8 weeks (56 days) following surgery, animals were culled between 1200 and 
1700, h by cervical dislocation followed by decapitation. White adipose tissue 
depots (right inguinal, right parametrial, right retroperitoneal and mesenteric) 
and the interscapular brown adipose tissue were removed and weighed. Total 
adipose tissue mass was estimated as the sum of the mass of these white 
adipose tissue depots. Brown adipose tissue was frozen then stored at −80 °C for 
subsequent analysis. 
. 
Western blotting 
Brown adipose tissue samples were homogenized in RIPA buffer (25 mM Tris-HCl 
pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) 
supplemented with Complete Protease Inhibitor Cocktail Tablets (Roche 
Diagnostic, Mannheim, Germany). Following centrifugation, supernatants were 
collected and protein concentrations were measured spectrophotometrically. 
Fifteen microgram protein were resolved by SDS-PAGE and immunoblotted with 
antibodies against uncoupling protein-1 (UCP-1) (Alpha Diagnostic International, 
San Antonio, TX, USA) and peroxisome proliferator activated receptor γ 
coactivator 1 α (PGC1α) (Calbiochem, Merck Pty Ltd, Kilsyth, Victoria, Australia). 
Immunolabelled bands were quantified by densitometry. 
. 
Serum estrogen and corticosterone analyses 
Blood samples were collected from the tail immediately after indirect calorimetry 
at both time points. Serum estradiol levels were measured at the long-term time 
point using an enzyme-linked immunosorbent assay kit (Cayman Chemical, Ann 
Arbor, MI, USA). Serum corticosterone levels were determined at both time 
points using a radioimmunoassay kit (MP Biomedicals, Solon, OH, USA). 
. 
Statistical analyses 
All data are expressed as means±s.e. of the mean (s.e.m.). Differences among 
groups were assessed by two-way analysis of variance (ANOVA) with Bonferroni 
post-hoc tests when appropriate. Differences in the overall time course between 
knockout and WT mice with respect to VO2, physical activity and RER over the 
continuous 72-h period were averaged for the whole 72-h period, as well as for 
the light and dark periods, were assessed by two-way ANOVA with repeated 
measures. Comparisons of energy expenditure (kcal per h) and resting metabolic 
rate (kcal per h) were carried out by analysis of covariance with lean mass as a 
covariate. Adjusted means of energy expenditure or resting metabolic rate at a 
common lean mass were generated by analysis of covariance and presented. 
When significant interactions between genotype and surgery were observed, 
energy expenditure and resting metabolic rate data were split for genotype or 
surgery and analyzed by analysis of covariance. Statistical analyses were 
performed with SPSS version 18.0 (SPSS, Chicago, IL, USA). Statistical 
significance was defined as P<0.05. 
 
Zengin	  et	  al.:	  NPY	  mediates	  hypometabolic	  effect	  of	  ovariectomy	  	  
International	  Journal	  of	  Obesity,	  37(3):	  390-­‐398,	  2013	  	  
RESULTS 
Effect of NPY deficiency on OVX-induced obesity 
To investigate the interaction between the NPY and estrogen pathways, we first 
examined body weight, body composition and food intake. Our model of OVX was 
found to be effective in all animals, as demonstrated by decreased uterine weight 
in WT and NPY−/− OVX animals relative to sham controls (WT: 1.4±0.3 versus 
10.2±1.4 mg; NPY−/−: 1.5±0.1 versus 10.1±1.3 mg, 8–11 mice per group, 
P<0.0001 OVX versus sham). In addition, serum estrogen was reduced to 
undetectable levels by OVX in both genotypes, and levels in sham controls were 
not significantly different between genotypes (25.8±2.1 versus 29.6±3.7 pg ml−1 
in WT and NPY−/− mice, respectively. 6–8 mice per group, ns). Before surgery, all 
groups showed similar body weights (19.1±0.5 g in WT sham; 19.0±0.6 g in WT 
OVX; 18.2±0.5 g in NPY−/− sham; 18.4±0.4 g in NPY−/− OVX, 9–11 mice per group, 
ns). There was no significant difference between sham WT and NPY−/− mice with 
respect to body weight changes in the 8 weeks after surgery (fig1Figures 1a and 
b). At the short-term time point following OVX, WT but not NPY−/− mice exhibited 
increased body weight when compared with sham controls of the same genotype 
(fig1Figure 1b). However, at the long-term period of estrogen deficiency, OVX 
induced an increase in body weight in both WT and NPY−/− mice (fig1Figure 1b). 
 
 Dual-energy X-ray absorptiometry at both the early and late time points 
revealed that significant OVX-induced increases in fat mass in both genotypes 
were not observed until the long-term time point (fig1Figure 1c), which was also 
demonstrated by the weight of individual white adipose tissue depots dissected at 
the long-term point (Supplemental Figure 1). In fact, there was a significant 
reduction in whole-body fat mass at the short-term time point in OVX NPY−/− 
carried out by analysis of covariance with lean mass as a covariate.
Adjusted means of energy expenditure or resting metabolic rate at a
common lean mass were generated by analysis of covariance and
presented. When significant interactions between genotype and surgery
were observed, energy expenditure and resting metabolic rate data were
split for genotype or surgery and analyzed by analysis of covariance.
Statistical analyses were performed with SPSS version 18.0 (SPSS, Chicago,
IL, USA). Statistical significance was defined as Po0.05.
RESULTS
Effect of NPY deficiency on OVX-induced obesity
To investigate the interaction between the NPY and estrogen
pathways, we first examined body weight, body composition and
food intake. Our model of OVX was found to be effective in all
animals, as demonstrated by decreased uterine weight in WT and
NPY! /! OVX animals relative to sham controls (WT: 1.4±0.3
versus 10.2±1.4mg; NPY! /! : 1.5±0.1 versus 10.1±1.3mg, 8–11
mice per group, Po0.0001 OVX versus sham). In addition, serum
estrogen was reduced to undetectable levels by OVX in both
genotypes, and levels in sham controls were not significantly
different between genotypes (25.8±2.1 versus 29.6±3.7 pgml! 1
in WT and NPY! /! mice, respectively. 6–8 mice per group, ns).
Before surgery, all groups showed similar body weights
(19.1±0.5 g in WT sham; 19.0±0.6 g in WT OVX; 18.2±0.5 g
in NPY! /! sham; 18.4±0.4 g in NPY! /! OVX, 9–11 mice per
group, ns). There was no significant difference betwee sham WT
and NPY! /! mice with respect to body weight changes in the
8 weeks after surgery (Figures 1a and b). At the short-term time
point following OVX, WT but not NPY! /! mice exhibited
increased body weight when compared with sham controls of
the same genotype (Figure 1b). However, at the long-term period
of estrogen deficiency, OVX induced an increase in body weight in
both WT and NPY! /! mice (Figure 1b).
Dual-energy X-ray absorptiometry at both the early and late
time points revealed that significant OVX-induced increases in fat
mass in both genotypes were not observed until the long-term
time point (Figure 1c), which was also demonstrated by the
weight of individual whit adipose tissue depots dissected at the
long-term point (Supplemental Figure 1). In fact, there was a
significant reduction in whole-body fat mass at the short-term
time point in OVX NPY! /! versus OVX WT mice (Figure 1c),
suggesting that NPY may indeed have a role in promoting fat
accretion in the initial 18 days following estrogen deficiency in
mice. Interestingly, at the short-term, but not the long-term time
point, OVX induced a signific nt increase in wh le-body lean mass
in WT and NPY! /! relative to sham animals of the same
genotype, with no significant difference between genotypes
(Figure 1d).
There was no significa t effect of OVX on food intake in WT or
NPY! /! mice at either time point (Figure 1e). However, NPY! /!
mice exhibited significantly decreased average daily food intake
compared with WT mice at the short-term tim point (Figure 1e).
This indicates that the increases in body weight and fat mass seen
in OVX mice of either genotype occur in the absence of any
increase in food intake at these time points.
Brown adipose tissue is an important regulator of energy
balance in rodents.37 We showed that NPY deficiency per se
significantly increased brown adipose tissue weight, with no
significant effect of OVX in mice of either genotype (Figure 2a).
There was no significant effect of OVX on UCP-1 or PGC1a
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Figure 1. NPY deficiency does not prevent OVX-induced obesity. (a, b) OVX increases weight gain and body weight in both WT and NPY
knockout mice relative to sham control mice. (c) Dual-energy X-ray absorptiometry (DXA) scans at 18 and 54 days post surgery, referred to as
‘short-term’ and ‘long-term’ time-points, respectively, reveal that OVX-induced increases in whole-body fat mass in both genotypes occur only
after long-term estrogen deficiency, with NPY! /! mice exhibiting a reduction in fat mass after short-term estrogen deficiency. Dual-energy
X-ray absorptiometry (DXA) scans (d) show that short-term estrogen deficiency increases whole-body lean mass in WT and NPY! /! mice.
(e) Average daily food intake measured over four consecutive days demonstrates that OVX had no effect on food intake in WT or NPY! /!
mice at either the short-term or long-term time points, with decreased average daily food intake in NPY! /! versus WTmice at the short-term
time point. Data are means±s.e.m. of 8–11 mice per group. *Po0.05 for comparisons within genotype. #Po0.05 for comparisons within
surgery type.
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versus OVX WT mice (fig1Figure 1c), suggesting that NPY may indeed have a role 
in promoting fat accretion in the initial 18 days following estrogen deficiency in 
mice. Interestingly, at the short-term, but not the long-term time point, OVX 
induced a significant increase in whole-body lean mass in WT and NPY−/− relative 
to sham animals of the same genotype, with no significant difference between 
genotypes (fig1Figure 1d). 
 There was no significant effect of OVX on food intake in WT or NPY−/− mice 
at either time point (fig1Figure 1e). However, NPY−/− mice exhibited significantly 
decreased average daily food intake compared with WT mice at the short-term 
time point (fig1Figure 1e). This indicates that the increases in body weight and 
fat mass seen in OVX mice of either genotype occur in the absence of any 
increase in food intake at these time points. 
 Brown adipose tissue is an important regulator of energy balance in 
rodents.bib3737 We showed that NPY deficiency per se significantly increased brown 
adipose tissue weight, with no significant effect of OVX in mice of either genotype 
(fig2Figure 2a). There was no significant effect of OVX on UCP-1 or PGC1α 
expression in WT or NPY−/− mice (fig2Figures 2b–d), however, NPY deficiency 
significantly decreased brown adipose tissue UCP-1 expression in both sham and 
OVX animals (fig2Figures 2b–d). Interestingly, OVX decreased PGC1α expression 
in NPY−/− mice compared with sham-operated knockouts, and NPY−/− OVX mice 
exhibited significantly reduced PGC1α expression relative to WT OVX mice 
(fig2Figures 2c and d). These data suggest that NPY is critical for the regulation 
of UCP-1 and PGC1α, particularly under conditions of estrogen deficiency. 	  
	  	  
NPY deficiency prevents the short-term reduction in oxygen consumption 
and energy expenditure induced by estrogen deficiency 
At the short-term time point, OVX WT mice exhibited significant reductions in 
oxygen consumption and energy expenditure compared with sham-operated 
controls, during the light and/or the dark phase (fig3Figures 3a–d). In contrast, 
this OVX-induced reduction in oxygen consumption was not seen in NPY−/− mice 
(fig3Figures 3a and b). Indeed, the oxygen consumption of NPY−/− OVX mice was 
not significantly different from sham-operated WT mice, and was significantly 
greater than that of WT OVX mice (fig3Figures 3a and b). Furthermore, energy 
expenditure of sham-operated NPY−/− mice was significantly lower than sham WT 
mice, as determined by repeated measures ANOVA (fig3Figure 3c). Unlike the 
OVX-induced drop in energy expenditure seen in WT mice, OVX in NPY−/− mice 
induced significant increases in 24  h and light phase energy expenditure 
(fig3Figures 3c and d). There were no significant differences in food intake among 
groups during these measurements of energy metabolism after short-term 
expression in WT or NPY! /! mice (Figures 2b–d), however, NPY
deficiency significantly decreased brown adipose tissue UCP-1
expression in both sham and OVX animals (Figures 2b–d).
Interestingly, OVX decreased PGC1a expression in NPY! /! mice
compared with sham-operated knockouts, and NPY! /! OVX mice
exhibited significantly reduced PGC1a expression relative to WT
OVX mice (Figures 2c and d). These data suggest that NPY is
critical for the regulation of UCP-1 and PGC1a, particularly under
conditions of estrogen deficiency.
NPY deficiency prevents the short-term reduction in oxygen
consumption a d energy expenditure induced by estrogen
deficiency
At the short-term time point, OVX WT mice exhibited significant
reductions in oxygen consumption and energy expenditure
compared with sham-operated controls, during the light and/or
the dark phase (Figures a–d). In contrast, this OVX-induced
reduction in oxygen consumption was not seen in NPY! /! mice
(Figures 3a and b). Indeed, the oxygen consumption of NPY! /!
OVX mice was not significantly different from sham-operated WT
mice, and was significantly greater than that of WT OVX mice
(Figures 3a and b). Furthermore, energy expenditure of sham-
operated NPY! /! mice was significantly lower than sham WT
mice, as determined by repeated measures ANOVA (Figure 3c).
Unlike the OVX-induced drop in energy expenditure seen in
WT mice, OVX in NPY! /! mice induced significant increases
in 24 h and light phase energy expenditure (Figures 3c and d).
There were no significant differences in food intake among
groups during these measurements of energy metabolism after
short-term estrogen deficiency (Table 1), demonstrating that
the observed differences in oxygen consumption and energy
expenditure were independent of differences in food intake.
Thus, the effect of OVX to reduce oxygen consumption and
energy expenditure during the initial phase of estrogen deficiency
is dependent upon NPY.
OVX had no significant effect on physical activity at the short-
term time point in WT or NPY! /! mice; however, NPY! /! mice
exhibited significantly lower activity levels than WT (Figures 3e
and f). In addition, there was a significant effect of genotype on
RER over the 24-h period and during the light phase, with both
sham-operated and OVX NPY! /! mice displaying a reduced RER
compared with WT mice, determined by repeated measures
ANOVA (Figures 3g and h). Hence, NPY! /! mice may preferen-
tially use fat as a fuel source compared with WT mice.
Long-term estr gen deficiency has no effect on energy
metabolism in WT or NPY! /! mice
The significant decreases in oxygen consumption and energy
expenditure observed in WT mice at the short-term time point
following OVX were no longer apparent at the long-term time
point (Figures 4a–d). Moreover, there was no significant effect
of NPY deficiency per se on oxygen consumption or energy
expenditure at the long-term time point after surgery (Figures
4a–d). However, consistent with the effects seen at the short-time
point, there was a tren to an increase in energy expenditure
following OVX in NPY! /! mice, reaching statistical significance
during the light period (Figure 4d).
Food intake measured during indirect calorimetry at the
long-term time point showed no differences among groups
(Table 1), consistent with the long-term food intake data shown
in Figure 1e.
Physical activity was unchanged by OVX in WT or NPY! /! mice,
albeit NPY! /! mice exhibited significan ly reduced activity levels
relative to WT counterparts at the long-term time point (Figures 4e
and f), consistent with the data collected at the short-term time
point (Figures 3e and f). Also consistent with data collected at the
short-time point, there was a significant effect of genotype on RER
during the light phase as determined by repeated measures
ANOVA (Figure 4g), with no effect of OVX (Figures 4g and h),
suggesting that NPY deficiency increases fat oxidation. Together,
the data in Figures 3 and 4 suggest that the effects of OVX on
oxygen consumption and energy expenditure are transient, and
that NPY is critical to these short-term effects of estrogen
deficiency.
Resting metabolic rate increases with simultaneous estrogen
and NPY deficiency
Our observation of changes in oxygen consumption and energy
expenditure in the absence of corresponding changes in physical
activity (Figures 3a–f and 4a–f) suggest that the differences may
be because of differences in resting metabolic rate, the largest
component of daily energy expenditure.38 OVX in WT mice
produced a transient trend to decreased resting metabolic rate
that was seen at the short- but not at the long-term time point
(Figure 5a). Importantly, this reduction was not observed in
OVX NPY! /! mice (Figure 5a). In fact, resting metabolic rate
was significantly increased by OVX in NPY! /! mice relative to
intact NPY! /! controls or sham-operated WT mice at both the
short-term and the long-term time points of estrogen deficiency
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Figure 2. NPY deletion decreases markers of thermogenesis in estrogen deficiency. (a) Dissected interscapular brown adipose tissue weight as
a percent of body weight is increased in NPY! /! relative to WT mice, with no significant effect of OVX relative to sham operation in either
genotype. (b) Quantification of western blot analysis demonstrates that NPY deficiency decreases brown adipose tissue uncoupling protein-1
(UCP-1) protein levels relative to corresponding WT values, with no significant effect of OVX versus sham operation in either genotype.
(c) PGC1a protein levels, as determined by quantification of western blots, are significantly lower in NPY! /! OVX versus WT OVX mice.
(d) Representative western blot showing protein levels of UCP-1 and PGC1a in sham-operated and OVX WT and NPY! /! mice. Data are
means±s.e.m. of six mice per group. *Po0.05 for comparisons within genotype. #Po0.05 for comparisons within surgery type.
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estrogen deficiency (tbl1Table 1), demonstrating that the observed differences in 
oxygen consumption and energy expenditure were independent of differences in 
food intake. Thus, the effect of OVX to reduce oxygen consumption and energy 
expenditure during the initial phase of estrogen deficiency is dependent upon 
NPY. 
 
 
 OVX had no significant effect on physical activity at the short-term time 
point in WT or NPY−/− mice; however, NPY−/− mice exhibited significantly lower 
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Figure 3. NPY deficiency prevents the reductions in oxygen consumption and energy expenditure in response to acute estrogen deficiency.
(a, b) At 14–18 days after surgery, ovariectomized (OVX) WT but not germline NPY knockout (NPY! /! ) mice exhibited significant reductions
in 24 h, light and dark phase oxygen consumption compared with sham-operated control mice. (c, d) OVX decreased 24 h and dark phase
energy expenditure in WT mice, whereas NPY! /! mice showed OVX-induced increases in energy expenditure. (e, f ) OVX has no significant
effect on physical activity; however, NPY deficiency reduced physical activity compared with WT. (g, h) RER was decreased with NPY
deficiency in the total 24-h period and in the light phase, with no significant effect of OVX. Energy expenditure was adjusted for lean mass by
analysis of covariance (ANCOVA). Adjusted energy expenditure was presented at a common lean mass of 15.22 g. Data are means±s.e.m.
of 8–11 mice per group, measured at 14–18 days post surgery. *Po0.05 for comparisons within genotype. #Po0.05 for comparisons within
surgery type. wPo0.05 for the interaction effect between surgery and genotype and fPo0.05 for the effect of genotype by repeated measures
ANOVA.
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activity levels than WT (fig3Figures 3e and f). In addition, there was a significant 
effect of genotype on RER over the 24-h period and during the light phase, with 
both sham-operated and OVX NPY−/− mice displaying a reduced RER compared 
with WT mice, determined by repeated measures ANOVA (fig3Figures 3g and h). 
Hence, NPY−/− mice may preferentially use fat as a fuel source compared with WT 
mice. 
 
Long-term estrogen deficiency has no effect on energy metabolism in WT 
or NPY−/− mice 
The significant decreases in oxygen consumption and energy expenditure 
observed in WT mice at the short-term time point following OVX were no longer 
apparent at the long-term time point (fig4Figures 4a–d). Moreover, there was no 
significant effect of NPY deficiency per se on oxygen consumption or energy 
expenditure at the long-term time point after surgery (fig4Figures 4a–d). 
However, consistent with the effects seen at the short-time point, there was a 
trend to an increase in energy expenditure following OVX in NPY−/− mice, reaching 
statistical significance during the light period (fig4Figure 4d). 
 
 Food intake measured during indirect calorimetry at the long-term time 
point showed no differences among groups (tbl1Table 1), consistent with the 
long-term food intake data shown in fig1Figure 1e. 
 Physical activity was unchanged by OVX in WT or NPY−/− mice, albeit 
NPY−/− mice exhibited significantly reduced activity levels relative to WT 
counterparts at the long-term time point (fig4Figures 4e and f), consistent with 
the data collected at the short-term time point (fig3Figures 3e and f). Also 
consistent with data collected at the short-time point, there was a significant 
effect of genotype on RER during the light phase as determined by repeated 
measures ANOVA (fig4Figure 4g), with no effect of OVX (fig4Figures 4g and h), 
suggesting that NPY deficiency increases fat oxidation. Together, the data in 
fig3Figures 3 and fig44 suggest that the effects of OVX on oxygen consumption 
and energy expenditure are transient, and that NPY is critical to these short-term 
effects of estrogen deficiency. 
 
Resting metabolic rate increases with simultaneous estrogen and NPY 
deficiency 
Our observation of changes in oxygen consumption and energy expenditure in the 
absence of corresponding changes in physical activity (fig3Figures 3a–f and 
(Figure 5a). This finding indicates that these differences in oxygen
consumption or energy expenditure are driven, at least to some
extent, by changes in resting metabolic processes.
Serum corticosterone levels reduces with simultaneous estrogen
and NPY deficiency
Having seen strong reductions in physical activity in NPY! /!
compared ith WT mice, and knowing that the anxious
p enotype of NPY! /! mice coul contribute to reduced physical
activity,31 serum corticosterone levels were measured. However,
OVX NPY! /! mice exhibited marked reductions in serum
corticosterone levels relative to OVX WT mice, significantly so
after short-term estrogen deficiency (Figure 5b).
DISCUSSION
This study reveals that the decreases in oxygen consumption and
energy expenditure occurring in response to estrogen deficiency
are transient, as these changes were apparent only at 2 weeks, but
not at 7 weeks after OVX in mice. NPY is a critical mediator of the
sh rt-term decreases in oxygen consumption and energy
expenditure induced by estrogen deficiency, because NPY! /!
mice did not exhibit any such metabolic depression after OVX.
This finding extends previous observations that hypothalamic
NPY expression is increased in post-menopausal women28 and
transiently increased by OVX in rodents,7,29,30 by demonstrating
the functional significance of NPY in mediating metabolic effects
of estrogen deficiency. Importantly, NPY ablation led to a
significant decrease in whole-body fat mass relative to WT mice
at 2 weeks after OVX, suggesting that NPY contributes not only to
OVX-induced metabolic depression but also to OVX-induced fat
accretion.
Increases in sympathetic nervous activity and thyroid function
with NPY ablation may have contributed to the lack of hypo-
metabolic effects of short-term estrogen deficiency in NPY! /!
mice. It is known that estrogen deficiency in humans39 and
rodents increases sympathetic activity,40 as indicated by increased
circulating and hypothalamic catecholamine levels. This change
might be expected to increase metabolic rate following OVX,
as increases in sympathetic activity have been shown to increase
metabolic rate in rodents.39 However, the transient OVX-induced
increase in hypothalamic NPY expression in WT animals7,29,30
could have opposed any such hypermetabolic effect, as NPY
inhibits sympathetic nervous output as well as thyroid function,
with both changes depressing metabolic rate.27,41,42 In NPY-
deficient animals no such OVX-induced increase in hypo-
thalamic NPY expression could occur, nor any consequent
metabolic depression, resulting in neither reduction in oxygen
consumption nor change in metabolic rate relative to non-OVX
WT animals.
Despite abolishing the short-term hypometabolic effect of
estrogen deficiency and inducing a transient decrease in
whole-body fat mass, NPY ablation did not block the increases
in body weight and fat mass seen in response to long-term
estrogen deficiency. Adaptations in NPY! /! mice may have
overcompensated for the lack of NPY, thereby promoting
obesity in estrogen deficiency. However, previous studies in
NPY! /! mice have not revealed any changes in hypothalamic
immunoreactivity of possible candidate compensators, namely
agouti-related protein, pro-opiomelanocortin and cocaine-
amphetamine-regulated transcript.43,44 An alternate explanation
for the eventual OVX-induced obesity in NPY! /! mice is our
finding that these animals were hypermetabolic and hypophagic
relative to WT mice. Indeed, rodents placed on calorie restricted
diets exhibit increased body fat and decreased lean mass during
weight regain because of preferential replenishment of fat
stores.45,46 These changes may be due to adaptive responses to
energy deficiency, which have been shown to favor fat accretion
at the expense of lean tissues and bone.27 In keeping with this,
NPY! /! mice showed no compensatory gain in lean mass as a
consequence of the increase in energy deposition as fat and the
associated increase in weight.
Previous studies in humans19 and in rodents20,47,48 have shown
that estrogen deficiency leads to a decrease in physical activity
in association with the decrease in energy expenditure.19,20,47,48
However, it was not known from those studies whether the
associated reduction in energy expenditure was due entirely
to this reduction in physical activity, or whether reduced basal
metabolic rate may have also contributed. Our study has clearly
shown that OVX-induced reductions in oxygen consumption and
energy expenditure can occur in the absence of significant
reductions in activity, suggesting that estrogen deficiency also
reduces basal metabolic processes. Indeed, OVX reduced resting
metabolic rate by 18% in WT mice. Further evidence for indepen-
dent regulation of physical activity and resting metabolic rate is
our observation that physical activity was significantly reduced
in OVX NPY! /! mice despite significantly increased energy
expenditure and resting metabolic rate relative to corresponding
values in OVX WT animals.
The reduced oxygen consumption and energy expenditure in
response to estrogen deficiency raises the possibility that the
decrease in energy expenditure observed in women transitioning
through menopause19 may also be transient. If so, then targeting
intensive weight management programs to the early period of
estrogen deficiency may lead to better prevention of menopause-
induced obesity. Circumstantial evidence for this comes from a
randomized controlled trial in overweight post-menopausal
women aged 50 to 75 years.49 A 12-month exercise intervention
program resulted in significant losses of body weight (1.0%), intra-
abdominal fat (8.6 g cm! 2) and subcutaneous abdominal fat
(28.8 g cm! 2) compared with women randomized to the non-
exercise control arm.49 Furthermore, when the results were strati-
fied by age, women aged 50–59 years exhibited significantly
reduced body weight, total body fat and subcutaneous body
fat when compared with women aged 70–75 years, in which no
significant reductions in these parameters were observed.49 Taken
together, weight management interventions targeted to the short-
term rather than the long-term phase after estrogen deficiency may
have greater potential to reduce body weight and fat mass, albeit
human studies would be required to investigate this.
In summary, our findings demonstrate that the effect of estrogen
deficiency to reduce energy expenditure is transient, and that NPY is
an important mediator of this effect, possibly via known inhibitory
effects of NPY on the sympathetic nervous system and on thyroid
function. Despite this effect, long-term NPY deficiency in our
NPY! /! mice did not prevent OVX-induced weight and fat gain.
The relevance of these findings to changes in fat mass in women
around the time of menopause remains to be evaluated.
Table 1. Average daily food intake in wild-type (WT) and NPY
knockout (NPY! /! ) mice during indirect calorimetry is not affected
by ovariectomy (OVX)
WT NPY! /!
Sham OVX Sham OVX
Short-term 4.40±0.2 4.51±0.3 3.72±0.5 4.06±0.1
Long-term 4.83±0.2 4.06±0.1 3.86±0.1 3.85±0.5
Abbreviation: NPY, neuropeptide Y. Daily food intake (g) was measured
during indirect calorimetry at 14–18 days (‘short-term’) and 50–54 days
(‘long-term’) after OVX or sham operation. Data are means±s.e.m. of 8–11
mice per group. There were no significant differences between groups.
NPY mediates hypometabolic effect of ovariectomy
A Zengin et al
395
& 2013 Macmillan Publishers Limited International Journal of Obesity (2013) 390 – 398
Zengin	  et	  al.:	  NPY	  mediates	  hypometabolic	  effect	  of	  ovariectomy	  	  
International	  Journal	  of	  Obesity,	  37(3):	  390-­‐398,	  2013	  	  
fig44a–f) suggest that the differences may be because of differences in resting 
metabolic rate, the largest component of daily energy expenditure.bib3838 OVX in 
WT mice produced a transient trend to decreased resting metabolic rate that was 
seen at the short- but not at the long-term time point (fig5Figure 5a). 
Importantly, this reduction was not observed in OVX NPY−/− mice (fig5Figure 5a). 
In fact, resting metabolic rate was significantly increased by OVX in NPY−/− mice 
relative to intact NPY−/− controls or sham-operated WT mice at both the short-
term and the long-term time points of estrogen deficiency (fig5Figure 5a). This 
finding indicates that these differences in oxygen consumption or energy 
expenditure are driven, at least to some extent, by changes in resting metabolic 
processes. 
Serum corticosterone levels reduces with simultaneous estrogen and 
NPY deficiency 
Having seen strong reductions in physical activity in NPY−/− compared with WT 
mice, and knowing that the anxious phenotype of NPY−/− mice could contribute to 
reduced physical activity,bib3131 serum corticosterone levels were measured. 
However, OVX NPY−/− mice exhibited marked reductions in serum corticosterone 
levels relative to OVX WT mice, significantly so after short-term estrogen 
deficiency (fig5Figure 5b). 
 
DISCUSSION 
 
This study reveals that the decreases in oxygen consumption and energy 
expenditure occurring in response to estrogen deficiency are transient, as these 
changes were apparent only at 2 weeks, but not at 7 weeks after OVX in mice. 
NPY is a critical mediator of the short-term decreases in oxygen consumption and 
energy expenditure induced by estrogen deficiency, because NPY−/− mice did not 
exhibit any such metabolic depression after OVX. This finding extends previous 
observations that hypothalamic NPY expression is increased in post-menopausal 
womenbib2828 and transiently increased by OVX in rodents,bib77, bib2929, bib3030 by 
demonstrating the functional significance of NPY in mediating metabolic effects of 
estrogen deficiency. Importantly, NPY ablation led to a significant decrease in 
whole-body fat mass relative to WT mice at 2 weeks after OVX, suggesting that 
NPY contributes not only to OVX-induced metabolic depression but also to OVX-
induced fat accretion. 
        Increases in sympathetic nervous activity and thyroid function with NPY 
ablation may have contributed to the lack of hypometabolic effects of short-term 
estrogen deficiency in NPY−/− mice. It is known that estrogen deficiency in 
humansbib3939 and rodents increases sympathetic activity,bib4040 as indicated by 
increased circulating and hypothalamic catecholamine levels. This change might 
be expected to increase metabolic rate following OVX, as increases in sympathetic 
activity have been shown to increase metabolic rate in rodents.bib3939 However, 
the transient OVX-induced increase in hypothalamic NPY expression in WT 
animalsbib77, bib2929, bib3030 could have opposed any such hypermetabolic effect, as 
NPY inhibits sympathetic nervous output as well as thyroid function, with both 
changes depressing metabolic rate.bib2727, bib4141, bib4242 In NPY-deficient animals no 
such OVX-induced increase in hypothalamic NPY expression could occur, nor any 
consequent metabolic depression, resulting in neither reduction in oxygen 
consumption nor change in metabolic rate relative to non-OVX WT animals. 
      Despite abolishing the short-term hypometabolic effect of estrogen deficiency 
and inducing a transient decrease in whole-body fat mass, NPY ablation did not 
block the increases in body weight and fat mass seen in response to long-term 
estrogen deficiency. Adaptations in NPY−/− mice may have overcompensated for 
the lack of NPY, thereby promoting obesity in estrogen deficiency. However, 
previous studies in NPY−/− mice have not revealed any changes in hypothalamic 
immunoreactivity of possible candidate compensators, namely agouti-related  
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Figure 4. Long-term estrogen deficiency has no effect on energy metabolism in WT or germline NPY knockout (NPY! /! ) mice. (a, b) At 50–54
days after surgery, there was no significant difference between ovariectomized (OVX) and sham-operated WT and NPY! /! mice with respect
to oxygen consumption. (c, d) OVX had no significant effect on energy expenditure in WT mice when measured at 50–54 days post surgery.
NPY deficiency in sham-operated mice significantly decreased energy expenditure relative to WT control values, while OVX normalized this
difference. (e, f ) Long-term (50–54 days) estrogen deficiency in OVX WT or NPY! /! mice has no significant effect on physical activity, but
NPY! /! mice showed reduced physical activity compared with WT values. (g, h) RER is decreased with NPY deficiency in the light phase.
Energy expenditure was adjusted for lean mass by analysis of covariance (ANCOVA). Adjusted energy expenditure was presented at a
common lean mass of 16.76 g. Data are means±s.e.m. of 8–11 mice per group, measured at 50–54 days post-surgery. *Po0.05 for
comparisons within genotype. #Po0.05 for comparisons within surgery type. wPo0.05 for the interaction effect between surgery and
genotype and fPo0.05 for the effect of genotype by repeated measures ANOVA.
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protein, pro-opiomelanocortin and cocaine-amphetamine-regulated 
transcript.bib4343, bib4444 An alternate explanation for the eventual OVX-induced 
obesity in NPY−/− mice is our finding that these animals were hypermetabolic and 
hypophagic relative to WT mice. Indeed, rodents placed on calorie restricted diets 
exhibit increased body fat and decreased lean mass during weight regain because 
of preferential replenishment of fat stores.bib4545, bib4646 These changes may be due 
to adaptive responses to energy deficiency, which have been shown to favor fat 
accretion at the expense of lean tissues and bone.bib2727 In keeping with this, 
NPY−/− mice showed no compensatory gain in lean mass as a consequence of the 
increase in energy deposition as fat and the associated increase in weight. 
 
 
 
 
 Previous studies in humansbib1919 and in rodentsbib2020, bib4747, bib4848 have 
shown that estrogen deficiency leads to a decrease in physical activity in 
association with the decrease in energy expenditure.bib1919, bib2020, bib4747, bib4848 
However, it was not known from those studies whether the associated reduction 
in energy expenditure was due entirely to this reduction in physical activity, or 
whether reduced basal metabolic rate may have also contributed. Our study has 
clearly shown that OVX-induced reductions in oxygen consumption and energy 
expenditure can occur in the absence of significant reductions in activity, 
suggesting that estrogen deficiency also reduces basal metabolic processes. 
Indeed, OVX reduced resting metabolic rate by 18% in WT mice. Further evidence 
for independent regulation of physical activity and resting metabolic rate is our 
observation that physical activity was significantly reduced in OVX NPY−/− mice 
despite significantly increased energy expenditure and resting metabolic rate 
relative to corresponding values in OVX WT animals. 
 The reduced oxygen consumption and energy expenditure in response to 
estrogen deficiency raises the possibility that the decrease in energy expenditure 
observed in women transitioning through menopausebib1919 may also be transient. 
If so, then targeting intensive weight management programs to the early period 
of estrogen deficiency may lead to better prevention of menopause-induced 
obesity. Circumstantial evidence for this comes from a randomized controlled trial 
in overweight post-menopausal women aged 50 to 75 years.bib4949 A 12-month 
exercise intervention program resulted in significant losses of body weight 
(1.0%), intra-abdominal fat (8.6 g cm−2) and subcutaneous abdominal fat (28.8 g 
cm−2) compared with women randomized to the non-exercise control arm.bib4949 
Furthermore, when the results were stratified by age, women aged 50–59 years 
exhibited significantly reduced body weight, total body fat and subcutaneous 
body fat when compared with women aged 70–75 years, in which no significant 
reductions in these parameters were observed.bib4949 Taken together, weight 
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Figure 5. OVX increases resting metabolic rate in NPY deficiency and simultaneously reduces serum corticosterone levels. (a) OVX in WT mice
produces a transient decrease in resting metabolic rate at 14–18 days (‘short-term’) but not at 50–54 days (‘long-term’) after surgery relative to
sham-operated WT mice. In contrast, resting metabolic rate was significantly increased after OVX in NPY! /! mice after both short-term and
long-term estrogen deficiency. Resting metabolic rate was adjusted for lean mass by analysis of covariance (ANCOVA). Adjusted resting
metabolic rate was presented at a common lean mass of 15.34 g during the short-term time point and 16.76 g at the long-term time point.
(b) OVX decreased serum corticosterone levels in NPY! /! mice after both short-term and long-term estrogen deficiency, with no effect
in WT mice. Data are means±s.e.m. of 8–11 mice per group; *Po0.05 for comparisons within genotype. #Po0.05 for comparisons within
surgery type.
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management interventions targeted to the short-term rather than the long-term 
phase after estrogen deficiency may have greater potential to reduce body weight 
and fat mass, albeit human studies would be required to investigate this. 
In summary, our findings demonstrate that the effect of estrogen deficiency to 
reduce energy expenditure is transient, and that NPY is an important mediator of 
this effect, possibly via known inhibitory effects of NPY on the sympathetic 
nervous system and on thyroid function. Despite this effect, long-term NPY 
deficiency in our NPY−/− mice did not prevent OVX-induced weight and fat gain. 
The relevance of these findings to changes in fat mass in women around the time 
of menopause remains to be evaluated. 
 
AKNOWLEDGMENTS 
 
We gratefully acknowledge the staff of the Garvan Institute Biological Testing 
Facility for facilitation of these experiments. AZ is supported by an Australian 
Postgraduate Award; IPLW is supported by the University of New South Wales 
Postgraduate Award; HH, PB and AS are supported by a Fellowship and Career 
Development Awards from the National Health and Medical Research Council 
(NHMRC) of Australia. The NHMRC has additionally supported this work with grant 
#596840. Author Contributions: AZ, HH, PAB and AS designed research; AZ, 
ADN, IPLW, RFE performed research; AZ and LZ analyzed data; AZ and AS wrote 
the paper and HH, LZ, JAE and PB provided critical review of the manuscript. 
 
REFERENCES 
 
1  Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R et al. Body 
weight, body fat distribution, and hormonal replacement therapy in early postmenopausal 
women. J Clin Endocrinol Metab 1997; 82: 414–417.   
2  Ho SC, Wu S, Chan SG, Sham A. Menopausal transition and changes of body 
composition: a prospective study in Chinese perimenopausal women. Int J Obes 2010; 34: 
1265–1274.   
3  Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH et al. Adipokines, 
inflammation, and visceral adiposity across the menopausal transition: a pro- spective 
study. J Clin Endocrinol Metab 2009; 94: 1104–1110.   
4  Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol 
Metab 2003; 88: 2404–2411.   
5  Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue 
metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol 
Metab. 2002; 87: 4166–4170.   
6  Tchernof A, Desmeules A, Richard C, Laberge P, Daris M, Mailloux J et al. Ovarian 
hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 
2004; 89: 3425–3430.   
7  Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen 
deficiency causes central leptin insensitivity and increased hypothalamic neuro- peptide Y. 
Int J Obes Relat Metab Disord 2001; 25: 1680–1688.   
8  Allison SJ, Baldock PA, Enriquez RF, Lin E, During M, Gardiner EM et al. Critical interplay 
between neuropeptide Y and sex steroid pathways in bone and adipose tissue 
homeostasis. J Bone Miner Res 2009; 24: 294–304.   
9  Asarian L, Geary N. Modulation of appetite by gonadal steroid hormones. Philos Trans R 
Zengin	  et	  al.:	  NPY	  mediates	  hypometabolic	  effect	  of	  ovariectomy	  	  
International	  Journal	  of	  Obesity,	  37(3):	  390-­‐398,	  2013	  	  
Soc Lond B Biol Sci 2006; 361: 1251–1263.   
10  Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensi- tivity 
to central leptin and insulin. Diabetes 2006; 55: 978–987.   
11  Larsson L, Grimby G, Karlsson J. Muscle strength and speed of move- ment in relation 
to age and muscle morphology. J Appl Physiol 1979; 46: 451–456.   
12  Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J et al. Age and gender 
comparisons of muscle strength in 654 women and men aged 20-93yr. J Appl Physiol 
1997; 83: 1581–1587.   
13 Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in body fat 
distribution. Ann N Y Acad Sci 2000; 904: 502–506.  
14 dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MM. Relationship of body fat 
distribution by waist circumference, dual-energy X-ray absorptiometry and 
ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in 
obese and non-obese postmenopausal women. Gynecol Endocrinol 2005; 21: 295–301.  
15 Milewicz A, Jedrzejuk D, Dunajska K, Lwow F. Waist circumference and serum 
adiponectin levels in obese and non-obese postmenopausal women. Maturitas 2010; 65: 
272–275.  
16 Jacobsen DE, Samson MM, Kezic S, Verhaar HJ. Postmenopausal HRT and tibolone in 
relation to muscle strength and body composition. Maturitas 2007; 58: 7–18. 17 
Mattiasson I, Rendell M, Tornquist C, Jeppsson S, Hulthen UL. Effects of estrogen  
replacement therapy on abdominal fat compartments as related to glucose and lipid 
metabolism in early postmenopausal women. Horm Metab Res 2002; 34: 583–588.  
18 Pedersen SB, Bruun JM, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and 
UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle 
in rats by estrogen. Biochem Biophys Res Commun 2001; 288: 191–197.  
19 Lovejoy JC. Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and 
decreased energy expenditure during the menopausal transition. Int J Obes 2008; 32: 
949–958.  
20 Isken F, Pfeiffer AF, Nogueiras R, Osterhoff MA, Ristow M, Thorens B et al. Deficiency of 
glucose-dependent insulinotropic polypeptide receptor prevents ovariectomy-induced 
obesity in mice. Am J Physiol Endocrinol Metab 2008; 295: E350–E355.  
21 Li HY, Blaustein JD, De Vries GJ, Wade GN. Estrogen-receptor immunoreactivity in 
hamster brain: preoptic area, hypothalamus and amygdala. Brain Res 1993; 631: 304–
312.  
22 Fahrbach SE, Meisel RL, Pfaff DW. Preoptic implants of estradiol increase wheel running 
but not the open field activity of female rats. Physiol Behav 1985; 35: 985–992.  
23 King JM. Effects of lesions of the amygdala, preoptic area, and hypothalamus on 
estradiol-induced activity in the female rat. J Comp Physiol Psychol 1979; 93: 360–367.  
24 Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, Clegg DJ et al. Silencing of estrogen 
receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. 
Proc Natl Acad Sci USA 2007; 104: 2501–2506.  
25 Ogawa S, Chan J, Gustafsson JA, Korach KS, Pfaff DW. Estrogen increases loco- motor 
activity in mice through estrogen receptor alpha: specificity for the type of activity. 
Endocrinology 2003; 144: 230–239.  
Zengin	  et	  al.:	  NPY	  mediates	  hypometabolic	  effect	  of	  ovariectomy	  	  
Internationla	  Journal	  of	  Obesity,	  37(3):	  390-­‐398,	  2013	  	  
26 Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected 
into the hypothalamus: a powerful neurochemical inducer of hyper- phagia and obesity. 
Peptides 1986; 7: 1189–1192.  
27 Sainsbury A, Zhang L. Role of the arcuate nucleus of the hypothalamus in regulation of 
body weight during energy deficit. Mol Cell Endocrinol 2010; 316: 109–119.  
28 Escobar CM, Krajewski SJ, Sandoval-Guzman T, Voytko ML, Rance NE. Neuro- peptide Y 
gene expression is increased in the hypothalamus of older women. J Clin Endocrinol Metab 
2004; 89: 2338–2343.  
29  Clegg DJ, Brown LM, Zigman JM, Kemp CJ, Strader AD, Benoit SC et al. Estradiol- 
dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 2007; 
56: 1051–1058.   
30  Shimizu H, Ohtani K, Kato Y, Tanaka Y, Mori M. Withdrawal of [corrected] estrogen 
increases hypothalamic neuropeptide Y (NPY) mRNA expression in ovar- iectomized obese 
rat. Neurosci Lett 1996; 204: 81–84.   
31  Karl T, Duffy L, Herzog H. Behavioural profile of a new mouse model for NPY 
deficiency. Eur J Neurosci 2008; 28: 173–180.   
32  Zhang L, Macia L, Turner N, Enriquez RF, Riepler SJ, Nguyen AD et al. Peripheral 
neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion. Int J Obes 2010; 
34: 357–373.   
33  Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988; 
37: 287–301.   
34  Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J 
Appl Physiol 1983; 55: 628–634.   
35  Mclean JA, Tobin G. Animal and Human Calorimetry. Cambridge University Press: New 
York, 1987, p352.   
36  Bjursell M, Gerdin AK, Lelliott CJ, Egecioglu E, Elmgren A, Tornell J et al. Acutely 
reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. 
Am J Physiol Endocrinol Metab 2008; 294: E251–E260.   
37  Giguere V. Transcriptional control of energy homeostasis by the estrogen-related 
receptors. Endocr Rev 2008; 29: 677–696.   
38  Poehlman ET, Horton ES. Regulation of energy expenditure in aging humans. Annu Rev 
Nutr 1990; 10: 255–275.   
39  Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot 
flashes. Fertil Steril 1998; 70: 332–337.   
40  Gomes HL, Graceli JB, Goncalves WL, dos Santos RL, Abreu GR, Bissoli NS et al. 
Influence of gender and estrous cycle on plasma and renal catecholamine levels in rats. 
Canadian journal of physiology and pharmacology 2012; 90: 75–82.   
41 Sainsbury A, Zhang L. Role of the hypothalamus in the neuroendocrine regula- tion of 
body weight and composition during energy deficit. Obes Rev 2012; 13: 234–257.  
42 Szekely M, Petervari E, Pakai E, Hummel Z, Acute Szelenyi Z. subacute and chronic 
effects of central neuropeptide Y on energy balance in rats. Neuropeptides 2005; 39: 103–
115.  
Zengin	  et	  al.:	  NPY	  mediates	  hypometabolic	  effect	  of	  ovariectomy	  	  
International	  Journal	  of	  Obesity,	  37(3):	  390-­‐398,	  2013	  	  
43 Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD. Effects of 
neuropeptide Y deficiency on hypothalamic agouti-related protein expression and 
responsiveness to melanocortin analogues. Brain Res 1999; 848: 66–77.  
44 Sousa-Ferreira L, Garrido M, Nascimento-Ferreira I, Nobrega C, Santos-Carvalho A, 
Alvaro AR et al. Moderate long-term modulation of neuropeptide Y in hypotha- lamic 
arcuate nucleus induces energy balance alterations in adult rats. PLoS One 2011; 6: 
e22333.  
45 Dulloo AG, Girardier L. Adaptive role of energy expenditure in modulating body fat and 
protein deposition during catch-up growth after early undernutrition. Am J Clin Nutr 1993; 
58: 614–621.  
46 Li X, Cope MB, Johnson MS, Smith Jr. DL, Nagy TR. Mild calorie restriction induces fat 
accumulation in female C57BL/6J mice. Obesity 2010; 18: 456–462.  
47 Rogers NH, Perfield 2nd JW, Strissel KJ, Obin MS, Greenberg AS. Reduced energy 
expenditure and increased inflammation are early events in the development of 
ovariectomy-induced obesity. Endocrinology 2009; 150: 2161–2168.  
48 Witte MM, Resuehr D, Chandler AR, Mehle AK, Overton JM. Female mice and rats 
exhibit species-specific metabolic and behavioral responses to ovariectomy. Gen Comp 
Endocrinol 2010; 166: 520–528.  
49 Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS et al. Effect of 
exercise on total and intra-abdominal body fat in postmenopausal women: a randomized 
controlled trial. JAMA 2003; 289: 323–330.  
 
 
